Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study.
<h4>Introduction</h4>Early identification of Alzheimer's disease (AD) is needed both for clinical trials and in clinical practice. In this study, we compared brief cognitive tests and cerebrospinal fluid (CSF) biomarkers in predicting conversion from mild cognitive impairment (MCI)...
Enregistré dans:
Auteurs principaux: | Sebastian Palmqvist, Joakim Hertze, Lennart Minthon, Carina Wattmo, Henrik Zetterberg, Kaj Blennow, Elisabet Londos, Oskar Hansson |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b5dbae0769b54b33891d9cbeaf202486 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Solitary living in Alzheimer’s disease over 3 years: association between cognitive and functional impairment and community-based services
par: Wattmo C, et autres
Publié: (2014) -
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis
par: Niklas Mattsson, et autres
Publié: (2016) -
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
par: Niklas Mattsson-Carlgren, et autres
Publié: (2021) -
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
par: Niklas Mattsson-Carlgren, et autres
Publié: (2020) -
Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.
par: Eugenia Trushina, et autres
Publié: (2013)